Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: An unusual adverse effect

Leore Lavin; Gabriella Chefitz; Deep Patel; Woong Kee Baek; Saakshi Khattri

doi:10.1016/j.jdcr.2024.04.023

Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: An unusual adverse effect

JAAD Case Rep. 2024 Apr 23:49:40-43. doi: 10.1016/j.jdcr.2024.04.023. eCollection 2024 Jul.

Authors

Leore Lavin¹, Gabriella Chefitz¹, Deep Patel¹, Woong Kee Baek², Saakshi Khattri¹

Affiliations

¹ Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
² Department of Pathology, Mount Sinai Morningside/West, New York, New York.

No abstract available

Keywords: atopic dermatitis; dupilumab; dupilumab adverse event; erythema multiforme; inflammation; prurigo nodularis; severe cutaneous adverse reaction.

Publication types

Case Reports